APA (7th ed.) Citation

Sacco, R., Giannini, E. G., Tortora, R., Di Costanzo, G. G., Mega, A., Marzi, L., . . . Pellicelli, A. (2025). Lenvatinib Is Highly Effective in Patients with Hepatocellular Carcinoma Related to Both Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Etiology: A Propensity Score Analysis. Cancers, 17(11), 1808. https://doi.org/10.3390/cancers17111808

Chicago Style (17th ed.) Citation

Sacco, Rodolfo, et al. "Lenvatinib Is Highly Effective in Patients with Hepatocellular Carcinoma Related to Both Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Etiology: A Propensity Score Analysis." Cancers 17, no. 11 (2025): 1808. https://doi.org/10.3390/cancers17111808.

MLA (9th ed.) Citation

Sacco, Rodolfo, et al. "Lenvatinib Is Highly Effective in Patients with Hepatocellular Carcinoma Related to Both Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Etiology: A Propensity Score Analysis." Cancers, vol. 17, no. 11, 2025, p. 1808, https://doi.org/10.3390/cancers17111808.